New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
ETF IssuersBMOZWHC
ZWHC

BMO Covered Call Health Care ETF

The ZWHC Exchange Traded Fund (ETF) is provided by BMO. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$27.00
+$0.1 (+0.37%) yesterday
1:31 PM 07/23/26 Open
1D price range
$27.00$27.00
52W price range
$24.87$29.64
YTD Perf.
+0.08%
YTD Flows
Annualized volatility
Fund AuM
€26M
Share class AuM
€26M
TTM Yield
Tracking Error
Tracking Difference
ISIN
CA05592T1093
TER
0.73%
Inception date
1/23/2023
Issuer
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 23, 2026
-10%-8%-6%-4%-2%0%2%4%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
100.83%
Latest ZWHC news

No content available for this fund

FAQ about ZWHC

ZWHC is a Active ETF. This ETF provides exposure to Health Care Equities.
ZWHC carries a total expense ratio (TER) of 0.73%, indicating the annual cost for holding the fund.
ZWHC was introduced to the market on January 23, 2023. It trades on Canada
BMO Covered Call Health Care ETF, ZWHC, is provided by BMO. Learn more about BMO here.
ZWHC oversees €26M in assets as of July 23, 2026.
ZWHC follows a distributing dividend policy, meaning it pays out income to investors. As of July 23, 2026, its 12-month trailing yield was 7.04%.
As of June 30, 2026, ZWHC has significant geographic allocations in USA and Ireland.
As of June 30, 2026, ZWHC focuses largely on Healthcare.
As of June 30, 2026, ZWHC holds 20 positions in its portfolio, with 80.38% of assets concentrated in its top 15 holdings.
As of June 30, 2026, ZWHC top three holdings include UnitedHealth Group, Inc., Eli Lilly & Co. and Elevance Health, Inc..
The base currency of ZWHC is CAD.
Data as of 06/30/26
UnitedHealth Group, Inc.
6.74%
Eli Lilly & Co.
6.49%
Elevance Health, Inc.
5.99%
Vertex Pharmaceuticals, Inc.
5.64%
Cardinal Health, Inc.
5.55%
Merck & Co., Inc.
5.41%
Johnson & Johnson
5.35%
Thermo Fisher Scientific, Inc.
5.14%
The Cigna Group
5.14%
Danaher Corp.
5.11%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight